SII’s Covovax becomes the fourth jab to be used for vaccination of 12-17 age group
The National Technical Advisory Group on Immunisation (NTAGI) has recommended Serum Institute of India's Covovax for vaccination of those aged 12 years and above.
India's drug regulator had approved Covid-19 vaccine Covovax for restricted…
Read More...
Read More...